MRPL30
gene geneOn this page
Also known as MRP-L28RPML28uL30m
Summary
MRPL30 (mitochondrial ribosomal protein L30, HGNC:14036) is a protein-coding gene on chromosome 2q11.2, encoding Large ribosomal subunit protein uL30m (Q8TCC3).
Mammalian mitochondrial ribosomal proteins are encoded by nuclear genes and help in protein synthesis within the mitochondrion. Mitochondrial ribosomes (mitoribosomes) consist of a small 28S subunit and a large 39S subunit. They have an estimated 75% protein to rRNA composition compared to prokaryotic ribosomes, where this ratio is reversed. Another difference between mammalian mitoribosomes and prokaryotic ribosomes is that the latter contain a 5S rRNA. Among different species, the proteins comprising the mitoribosome differ greatly in sequence, and sometimes in biochemical properties, which prevents easy recognition by sequence homology. This gene encodes a 39S subunit protein. Alternative splicing results in multiple transcript variants. Pseudogenes corresponding to this gene are found on chromosomes 6p and 12p. Read-through transcription also exists between this gene and the neighboring upstream lipoyltransferase 1 (LIPT1) gene.
Source: NCBI Gene 51263 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 36 total
- MANE Select transcript:
NM_145212
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:14036 |
| Approved symbol | MRPL30 |
| Name | mitochondrial ribosomal protein L30 |
| Location | 2q11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MRP-L28, RPML28, uL30m |
| Ensembl gene | ENSG00000185414 |
| Ensembl biotype | protein_coding |
| OMIM | 611838 |
| Entrez | 51263 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 7 protein_coding, 2 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay
ENST00000338148, ENST00000409145, ENST00000409841, ENST00000465432, ENST00000473743, ENST00000898902, ENST00000898903, ENST00000898904, ENST00000922468, ENST00000941877
RefSeq mRNA: 1 — MANE Select: NM_145212
NM_145212
CCDS: CCDS2041
Canonical transcript exons
ENST00000338148 — 6 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002263017 | 99181184 | 99181249 |
| ENSE00003459302 | 99195573 | 99199561 |
| ENSE00003640627 | 99195116 | 99195189 |
| ENSE00003705079 | 99194751 | 99194897 |
| ENSE00003705965 | 99188177 | 99188257 |
| ENSE00003711199 | 99186177 | 99186254 |
Expression profiles
Bgee: expression breadth ubiquitous, 256 present calls, max score 97.71.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 47.2109 / max 676.6745, expressed in 1815 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 21564 | 40.0041 | 1810 |
| 21563 | 7.2068 | 1686 |
Top tissues by expression
256 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| tibialis anterior | UBERON:0001385 | 97.71 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 97.32 | gold quality |
| pancreatic ductal cell | CL:0002079 | 96.99 | gold quality |
| ileal mucosa | UBERON:0000331 | 96.58 | gold quality |
| deltoid | UBERON:0001476 | 96.35 | gold quality |
| cardiac muscle of right atrium | UBERON:0003379 | 96.32 | gold quality |
| vastus lateralis | UBERON:0001379 | 96.28 | gold quality |
| quadriceps femoris | UBERON:0001377 | 95.68 | gold quality |
| myocardium | UBERON:0002349 | 95.62 | gold quality |
| gingival epithelium | UBERON:0001949 | 95.17 | gold quality |
| kidney epithelium | UBERON:0004819 | 95.15 | gold quality |
| biceps brachii | UBERON:0001507 | 94.79 | gold quality |
| calcaneal tendon | UBERON:0003701 | 94.37 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 94.32 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 94.20 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 94.01 | gold quality |
| endothelial cell | CL:0000115 | 94.00 | gold quality |
| amniotic fluid | UBERON:0000173 | 93.95 | gold quality |
| gingiva | UBERON:0001828 | 93.74 | gold quality |
| heart right ventricle | UBERON:0002080 | 93.70 | gold quality |
| muscle tissue | UBERON:0002385 | 93.67 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 93.53 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 93.49 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 93.29 | gold quality |
| tendon | UBERON:0000043 | 92.98 | gold quality |
| buccal mucosa cell | CL:0002336 | 92.92 | gold quality |
| parietal pleura | UBERON:0002400 | 92.51 | gold quality |
| tendon of biceps brachii | UBERON:0008188 | 92.51 | gold quality |
| parotid gland | UBERON:0001831 | 91.95 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 91.81 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 6.24 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
124 targeting MRPL30, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-6740-5P | 100.00 | 65.64 | 932 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-3185 | 99.99 | 68.12 | 1959 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-1229-3P | 99.97 | 66.49 | 906 |
| HSA-MIR-3688-3P | 99.97 | 72.02 | 2834 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-6778-3P | 99.96 | 67.29 | 2693 |
| HSA-MIR-539-5P | 99.93 | 70.30 | 2855 |
| HSA-MIR-515-5P | 99.92 | 69.82 | 2343 |
| HSA-MIR-519E-5P | 99.92 | 69.62 | 2358 |
| HSA-MIR-10527-5P | 99.91 | 72.28 | 3754 |
| HSA-MIR-4697-3P | 99.89 | 67.09 | 1123 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-30D-3P | 99.87 | 69.92 | 2917 |
| HSA-MIR-30A-3P | 99.87 | 69.74 | 2928 |
| HSA-MIR-30E-3P | 99.87 | 69.68 | 2942 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-4503 | 99.85 | 71.45 | 1869 |
| HSA-MIR-576-5P | 99.84 | 70.46 | 2582 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-3121-3P | 99.82 | 71.96 | 3630 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Mrpl30 | ENSMUSG00000026087 |
| rattus_norvegicus | Mrpl30 | ENSRNOG00000049330 |
| rattus_norvegicus | LOC120100611 | ENSRNOG00000063834 |
Protein
Protein identifiers
Large ribosomal subunit protein uL30m — Q8TCC3 (reviewed: Q8TCC3)
Alternative names: 39S ribosomal protein L28, mitochondrial, 39S ribosomal protein L30, mitochondrial
All UniProt accessions (2): B8ZZV5, Q8TCC3
UniProt curated annotations — full annotation on UniProt →
Subunit / interactions. Component of the mitochondrial large ribosomal subunit (mt-LSU). Mature mammalian 55S mitochondrial ribosomes consist of a small (28S) and a large (39S) subunit. The 28S small subunit contains a 12S ribosomal RNA (12S mt-rRNA) and 30 different proteins. The 39S large subunit contains a 16S rRNA (16S mt-rRNA), a copy of mitochondrial valine transfer RNA (mt-tRNA(Val)), which plays an integral structural role, and 52 different proteins.
Subcellular location. Mitochondrion.
Similarity. Belongs to the universal ribosomal protein uL30 family.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8TCC3-1 | 1 | yes |
| Q8TCC3-2 | 2 | |
| Q8TCC3-3 | 3 |
RefSeq proteins (1): NP_660213* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR005996 | Ribosomal_uL30_bact | Family |
| IPR016082 | Ribosomal_uL30_ferredoxin-like | Domain |
| IPR036919 | Ribo_uL30_ferredoxin-like_sf | Homologous_superfamily |
Pfam: PF00327
UniProt features (20 total): strand 8, helix 4, turn 2, splice variant 2, transit peptide 1, chain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
86 structures, top 30 by resolution.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7OF0 | ELECTRON MICROSCOPY | 2.2 |
| 7QI4 | ELECTRON MICROSCOPY | 2.21 |
| 8RRI | ELECTRON MICROSCOPY | 2.4 |
| 8QU5 | ELECTRON MICROSCOPY | 2.42 |
| 9OLF | ELECTRON MICROSCOPY | 2.46 |
| 7OF7 | ELECTRON MICROSCOPY | 2.5 |
| 7PO4 | ELECTRON MICROSCOPY | 2.56 |
| 6ZM6 | ELECTRON MICROSCOPY | 2.59 |
| 7O9M | ELECTRON MICROSCOPY | 2.6 |
| 7OF6 | ELECTRON MICROSCOPY | 2.6 |
| 9CN3 | ELECTRON MICROSCOPY | 2.62 |
| 7QI5 | ELECTRON MICROSCOPY | 2.63 |
| 7OF2 | ELECTRON MICROSCOPY | 2.7 |
| 7OF3 | ELECTRON MICROSCOPY | 2.7 |
| 7OF4 | ELECTRON MICROSCOPY | 2.7 |
| 8QU1 | ELECTRON MICROSCOPY | 2.74 |
| 9PR4 | ELECTRON MICROSCOPY | 2.77 |
| 9PRA | ELECTRON MICROSCOPY | 2.83 |
| 8ANY | ELECTRON MICROSCOPY | 2.85 |
| 6ZM5 | ELECTRON MICROSCOPY | 2.89 |
| 7QH7 | ELECTRON MICROSCOPY | 2.89 |
| 7ODR | ELECTRON MICROSCOPY | 2.9 |
| 7OF5 | ELECTRON MICROSCOPY | 2.9 |
| 8K2A | ELECTRON MICROSCOPY | 2.9 |
| 8OIT | ELECTRON MICROSCOPY | 2.9 |
| 9PGL | ELECTRON MICROSCOPY | 2.9 |
| 9PGF | ELECTRON MICROSCOPY | 2.93 |
| 6VMI | ELECTRON MICROSCOPY | 2.96 |
| 6VLZ | ELECTRON MICROSCOPY | 2.97 |
| 7QI6 | ELECTRON MICROSCOPY | 2.98 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8TCC3-F1 | 82.98 | 0.61 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-5368286 | Mitochondrial translation initiation |
| R-HSA-5389840 | Mitochondrial translation elongation |
| R-HSA-5419276 | Mitochondrial translation termination |
| R-HSA-9937383 | Mitochondrial ribosome-associated quality control |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-5368287 | Mitochondrial translation |
| R-HSA-72766 | Translation |
MSigDB gene sets: 144 (showing top):
GOBP_MITOCHONDRIAL_TRANSLATION, GOBP_TRANSLATION, WEI_MYCN_TARGETS_WITH_E_BOX, GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME, GOCC_MITOCHONDRIAL_ENVELOPE, GARY_CD5_TARGETS_DN, DODD_NASOPHARYNGEAL_CARCINOMA_UP, GCM_NF2, RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN, GOCC_LARGE_RIBOSOMAL_SUBUNIT, GOCC_RIBOSOME, GOCC_ORGANELLAR_RIBOSOME, GOCC_MITOCHONDRIAL_MATRIX, GOCC_ORGANELLE_INNER_MEMBRANE, GOCC_RIBOSOMAL_SUBUNIT
GO Biological Process (2): mitochondrial translation (GO:0032543), translation (GO:0006412)
GO Molecular Function (1): structural constituent of ribosome (GO:0003735)
GO Cellular Component (6): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), mitochondrial large ribosomal subunit (GO:0005762), ribosome (GO:0005840), large ribosomal subunit (GO:0015934), ribonucleoprotein complex (GO:1990904)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Mitochondrial translation | 4 |
| Translation | 1 |
| Metabolism of proteins | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 1 |
| translation | 1 |
| mitochondrial gene expression | 1 |
| peptidyltransferase activity | 1 |
| translational initiation | 1 |
| translational elongation | 1 |
| translational termination | 1 |
| macromolecule biosynthetic process | 1 |
| protein metabolic process | 1 |
| protein biosynthetic process | 1 |
| structural molecule activity | 1 |
| ribosome | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| organellar large ribosomal subunit | 1 |
| mitochondrial ribosome | 1 |
| mitochondrial protein-containing complex | 1 |
| intracellular membraneless organelle | 1 |
| ribosomal subunit | 1 |
| protein-containing complex | 1 |
Protein interactions and networks
STRING
1948 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MRPL30 | MRPL16 | Q9NX20 | 591 |
| MRPL30 | GADD45GIP1 | Q8TAE8 | 536 |
| MRPL30 | DDX49 | Q9Y6V7 | 530 |
| MRPL30 | MRPL34 | Q9BQ48 | 516 |
| MRPL30 | MRPS15 | P82914 | 504 |
| MRPL30 | MRPL11 | Q9Y3B7 | 501 |
| MRPL30 | MRPS14 | O60783 | 501 |
| MRPL30 | CCDC181 | Q5TID7 | 490 |
| MRPL30 | MRPL36 | Q9P0J6 | 475 |
| MRPL30 | POGK | Q9P215 | 472 |
| MRPL30 | SNRNP40 | Q96DI7 | 464 |
| MRPL30 | EVI5L | Q96CN4 | 461 |
| MRPL30 | AKAP17A | Q02040 | 458 |
| MRPL30 | MRPL40 | Q9NQ50 | 458 |
| MRPL30 | MRPS18B | Q9Y676 | 452 |
IntAct
77 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| S100B | S100A4 | psi-mi:“MI:0914”(association) | 0.870 |
| KBTBD7 | METTL15 | psi-mi:“MI:0914”(association) | 0.730 |
| YBX1 | SSB | psi-mi:“MI:0914”(association) | 0.710 |
| MALSU1 | NDUFAB1 | psi-mi:“MI:0914”(association) | 0.710 |
| FAM120A | SYNCRIP | psi-mi:“MI:0914”(association) | 0.640 |
| MRPS30 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.640 |
| MRPL50 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| FBXW11 | AHCYL1 | psi-mi:“MI:0914”(association) | 0.530 |
| PDGFB | DKC1 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL13 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL18 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| ABT1 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| MRPL27 | MRPL33 | psi-mi:“MI:0914”(association) | 0.530 |
| RPL13 | RRP8 | psi-mi:“MI:0914”(association) | 0.530 |
| NDUFAB1 | MIEF1 | psi-mi:“MI:0915”(physical association) | 0.490 |
| Brwd3 | WDR91 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL50 | MRPL43 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL9 | MRPL43 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL1 | MRPL43 | psi-mi:“MI:0914”(association) | 0.350 |
| ALYREF | psi-mi:“MI:0914”(association) | 0.350 | |
| CUL3 | PXDNL | psi-mi:“MI:0914”(association) | 0.350 |
| S100B | PLEKHG3 | psi-mi:“MI:0914”(association) | 0.350 |
| RPL27A | ZNF320 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL30 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| FAM120A | GTPBP10 | psi-mi:“MI:0914”(association) | 0.350 |
| LIN28B | ZNF316 | psi-mi:“MI:0914”(association) | 0.350 |
| MRPL33 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (215): MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS), MRPL30 (Synthetic Lethality), MRPL30 (Affinity Capture-MS), MRPL30 (Affinity Capture-MS)
ESM2 similar proteins: A6QPQ5, A9X1A9, O95707, P0C2C1, P82664, P82670, P82675, P82915, P82919, P82933, Q08BI9, Q0P5E7, Q0VFH6, Q2KIB9, Q2KID9, Q2KIJ6, Q2TBK2, Q2TBR2, Q3MHY7, Q3SYS0, Q3T040, Q58DQ5, Q58DV5, Q5C9Z4, Q5R7B0, Q5REJ1, Q5REY4, Q5RFM3, Q641X9, Q7Z2W9, Q7Z7H8, Q8N3Z3, Q8TCC3, Q924T2, Q99N85, Q99N87, Q99N94, Q9BSH4, Q9BYD2, Q9BYD6
Diamond homologs: A6LLN1, A7HM34, B7IHW4, C5D3T5, P0C2C1, Q4R6U7, Q58DV5, Q8TCC3, Q9D7N6
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MRPL30 | “form complex” | “39S mitochondrial large ribosomal subunit” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 85 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Mitochondrial ribosome-associated quality control | 25 | 51.2× | 4e-35 |
| Mitochondrial translation | 21 | 48.2× | 7e-29 |
| Mitochondrial translation initiation | 22 | 46.5× | 7e-30 |
| Mitochondrial translation elongation | 22 | 46.5× | 7e-30 |
| Mitochondrial translation termination | 22 | 40.3× | 1e-28 |
| Translation | 23 | 23.8× | 2e-24 |
| Peptide chain elongation | 7 | 14.8× | 2e-05 |
| Viral mRNA Translation | 7 | 14.8× | 2e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| mitochondrial translation | 22 | 47.2× | 5e-29 |
| translation | 20 | 25.4× | 1e-20 |
| negative regulation of translation | 7 | 16.9× | 2e-05 |
| cytoplasmic translation | 7 | 16.0× | 3e-05 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
36 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 24 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1262 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:99181165:GCTT:G | donor_gain | 1.0000 |
| 2:99186175:A:AG | acceptor_gain | 1.0000 |
| 2:99186176:G:GA | acceptor_gain | 1.0000 |
| 2:99186251:ACAGG:A | donor_loss | 1.0000 |
| 2:99186252:CAGG:C | donor_loss | 1.0000 |
| 2:99186253:AGG:A | donor_loss | 1.0000 |
| 2:99186254:GGT:G | donor_loss | 1.0000 |
| 2:99186255:GTA:G | donor_loss | 1.0000 |
| 2:99186256:T:A | donor_loss | 1.0000 |
| 2:99188176:GACT:G | acceptor_gain | 1.0000 |
| 2:99188258:G:GG | donor_gain | 1.0000 |
| 2:99194749:A:AG | acceptor_gain | 1.0000 |
| 2:99194749:AG:A | acceptor_gain | 1.0000 |
| 2:99194749:AGGT:A | acceptor_gain | 1.0000 |
| 2:99194750:G:GT | acceptor_gain | 1.0000 |
| 2:99194750:GG:G | acceptor_gain | 1.0000 |
| 2:99194750:GGT:G | acceptor_gain | 1.0000 |
| 2:99194750:GGTG:G | acceptor_gain | 1.0000 |
| 2:99194750:GGTGT:G | acceptor_gain | 1.0000 |
| 2:99194869:A:G | donor_gain | 1.0000 |
| 2:99194895:AAA:A | donor_gain | 1.0000 |
| 2:99194896:AA:A | donor_gain | 1.0000 |
| 2:99194896:AAGT:A | donor_loss | 1.0000 |
| 2:99194896:AAGTA:A | donor_loss | 1.0000 |
| 2:99194897:AG:A | donor_loss | 1.0000 |
| 2:99194898:G:GG | donor_gain | 1.0000 |
| 2:99194898:GT:G | donor_loss | 1.0000 |
| 2:99194899:T:A | donor_loss | 1.0000 |
| 2:99195167:A:T | donor_gain | 1.0000 |
| 2:99186171:CCACA:C | acceptor_loss | 0.9900 |
AlphaMissense
1050 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:99194824:T:A | V69D | 0.993 |
| 2:99195165:T:C | L110S | 0.993 |
| 2:99195142:T:A | N102K | 0.990 |
| 2:99195142:T:G | N102K | 0.990 |
| 2:99195139:G:C | K101N | 0.989 |
| 2:99195139:G:T | K101N | 0.989 |
| 2:99195174:T:A | V113D | 0.987 |
| 2:99194890:T:C | L91S | 0.985 |
| 2:99194831:A:C | R71S | 0.984 |
| 2:99194831:A:T | R71S | 0.984 |
| 2:99195183:T:C | L116S | 0.981 |
| 2:99195584:T:C | L122S | 0.981 |
| 2:99194817:C:G | H67D | 0.980 |
| 2:99194861:G:C | W81C | 0.980 |
| 2:99194861:G:T | W81C | 0.980 |
| 2:99195132:T:A | V99D | 0.979 |
| 2:99195181:T:A | H115Q | 0.979 |
| 2:99195181:T:G | H115Q | 0.979 |
| 2:99195186:T:A | I117K | 0.979 |
| 2:99194859:T:A | W81R | 0.976 |
| 2:99194859:T:C | W81R | 0.976 |
| 2:99194819:T:A | H67Q | 0.975 |
| 2:99194819:T:G | H67Q | 0.975 |
| 2:99195134:C:G | H100D | 0.975 |
| 2:99195157:T:A | N107K | 0.975 |
| 2:99195157:T:G | N107K | 0.975 |
| 2:99194851:G:C | R78P | 0.974 |
| 2:99188231:T:C | F36L | 0.972 |
| 2:99188233:C:A | F36L | 0.972 |
| 2:99188233:C:G | F36L | 0.972 |
dbSNP variants (sampled 300 via entrez): RS1000331959 (2:99186476 G>A), RS1000373733 (2:99183024 C>G), RS1000484307 (2:99198486 A>G,T), RS1000660028 (2:99181910 T>A,C), RS1000713355 (2:99181405 C>G), RS1000878095 (2:99188107 A>G), RS1000958619 (2:99198852 C>G), RS1000970612 (2:99194288 T>G), RS1001083660 (2:99192354 C>T), RS1001230088 (2:99191745 A>G), RS1001266553 (2:99188491 T>G), RS1001303782 (2:99191893 C>G,T), RS1001308161 (2:99194710 G>A), RS1001567564 (2:99179427 G>A), RS1001607199 (2:99198777 C>T)
Disease associations
OMIM: gene MIM:611838 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST001241_13 | Bipolar disorder | 3.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | increases abundance, increases expression, decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| bisphenol A | affects expression | 1 |
| kojic acid | decreases expression | 1 |
| trichostatin A | decreases expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| diallyl trisulfide | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| bisphenol S | increases expression | 1 |
| Bortezomib | decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Vorinostat | increases expression | 1 |
| Acetaminophen | affects cotreatment, increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Demecolcine | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Lipopolysaccharides | affects cotreatment, increases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Testosterone | decreases expression | 1 |
| Thiram | decreases expression | 1 |
| Valproic Acid | increases expression | 1 |
| Vincristine | decreases expression | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Antirheumatic Agents | increases expression | 1 |
| Cadmium Chloride | increases abundance, increases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.